What is LOPJLB’s current signal on HCAT?

LOPJLB’s latest quantitative signal on Health Catalyst, Inc. (HCAT) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is HCAT in?

Health Catalyst, Inc. (HCAT) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Health Catalyst, Inc. (HCAT) do?

Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into exi…

Health Catalyst, Inc. (HCAT)

COMPARE

Healthcare · Medical - Healthcare Information Services · NASDAQ · US

$1.75-1.13%Close

BUYRECOVERY · day 27

Company news

globenewswire.com · 29d ago

Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

prnewswire.com · 29d ago

Health Catalyst Strengthens Its Board with the Appointment of Tami Reller

globenewswire.com · 35d ago

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

defenseworld.net · 41d ago

Hsbc Holdings PLC Invests $809,000 in Health Catalyst, Inc. $HCAT

globenewswire.com · 43d ago

Health Catalyst to Participate in Upcoming Investor Conference

defenseworld.net · 50d ago

Critical Survey: Aclarion (NASDAQ:ACONW) and Health Catalyst (NASDAQ:HCAT)

defenseworld.net · 62d ago

Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of “Hold” from Analysts

defenseworld.net · 62d ago

Health Catalyst (NASDAQ:HCAT) and Lynx Global Digital Finance (OTCMKTS:CNONF) Head-To-Head Review

marketbeat.com · 67d ago

Health Catalyst Q2 Earnings Call Highlights

seekingalpha.com · 67d ago

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

zacks.com · 68d ago

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

zacks.com · 68d ago

Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates

prnewswire.com · 68d ago

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

globenewswire.com · 68d ago

Health Catalyst Reports Second Quarter 2026 Results

globenewswire.com · 77d ago

Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026

marketbeat.com · 89d ago

Health Catalyst Investors Approve Directors, Pay; Board Declassification Fails

Market news & ticker search · RSS for HCAT

FAQ

What is LOPJLB’s current signal on HCAT?: LOPJLB’s latest quantitative signal on Health Catalyst, Inc. (HCAT) is BUY in a RECOVERY regime. Signals are updated daily.
What market regime is HCAT in?: Health Catalyst, Inc. (HCAT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
What does Health Catalyst, Inc. (HCAT) do?: Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into exi…

Health Catalyst, Inc. (HCAT)

Key stats

Prediction markets

Company news

FAQ